Vetter and Rentschler progress joint CDMO collaborative work 04-Apr-2022 By Jane Byrne Vetter and Rentschler Biopharma are looking to boost the awareness and benefits of their strategic CDMO alliance.
Rentschler and Vetter cooperate to integrate services 09-Jul-2020 By Ben Hargreaves The CDMOs will launch pilot projects to determine where collaboration may help streamline drug development.
Rentschler enters agreement with Genmab for antibody manufacture 04-Jun-2020 By Ben Hargreaves Rentschler will manufacture Genmab’s bispecific antibodies and expand the US site where the work will take place.
Biologics CDMO buys Shire Massachusetts facility 02-Jan-2019 By Staff Reporter Rentschler Biopharma will buy Shire’s development and manufacturing facility in Milton, Massachusetts, where the latter makes haemophilia A product, Obizur, for commercial production.
